Business News • MarketWire • Corporate Profile's CPreports.com Features Goldman Small Cap Research and Issues Research Update on Rexahn Pharmaceuticals, Inc.

Corporate Profile's CPreports.com Features Goldman Small Cap Research and Issues Research Update on Rexahn Pharmaceuticals, Inc.

Corporate Profile's CPreports.com Features Goldman Small Cap Research and Issues Research Update on Rexahn Pharmaceuticals, Inc.

NEW YORK, NY--(Marketwire - April 12, 2010) - Corporate Profile's newest financial website, CPreports.com announces an Update. Goldman Small Cap Research, a stock market research firm focused on the small cap and micro cap sectors, has issued a research update on Rexahn Pharmaceuticals, Inc., (NYSE Amex: RNN), a clinical stage pharmaceutical company commercializing potential best-in-class oncology and CNS therapeutics. See update at http://www.cpreports.com or http://www.cpreports.com/?p=133

View More : http://www.marketwire.com/mw/release.do?id=1146227&sourceType=3

Releted News by marketwire

Dearborn National(TM) Introduces New Web Site

James Hahn Named Vice President of Sales for Transamerica Insurance & Investment Group